Ecolab Q2 Earnings: Adjusted EPS $2.09 Beats, Raises 2026 Outlook to $8.05-$8.25
ECL is trading near its 52-week low of $243.15 (12% above the low).
Summary
Ecolab reported Q2 2026 adjusted EPS of $2.09, up 11% year-over-year, and raised its full-year adjusted EPS guidance to $8.05-$8.25. Organic sales growth accelerated to 5%, driven by strong performance in Global High-Tech and Life Sciences.
Key Events · Earnings and Guidance · ECL
-
Q2 Adjusted EPS Beats, Up 11%
Adjusted diluted EPS of $2.09 exceeded expectations, rising 11% from $1.89 a year ago, driven by accelerating organic sales growth and strong productivity.
-
Full-Year Guidance Raised
Ecolab raised its 2026 adjusted diluted EPS outlook to $8.05-$8.25, up 7-10% year-over-year, from the prior range of $8.03-$8.23, reflecting confidence in accelerating pricing and volume growth.
-
Organic Sales Growth Accelerates to 5%
Organic sales growth improved to 5%, with volume up 1% despite Middle East disruptions and pricing improving to 4%, led by 29% growth in Global High-Tech and 15% in Life Sciences.
-
Q3 Guidance Initiated at $2.13-$2.23
Ecolab expects Q3 2026 adjusted diluted EPS of $2.13-$2.23, representing 3-8% growth, with organic sales growth expected to accelerate to 6-7% in the second half.
Analysis · ECL · Industrial Applications And Services
Ecolab delivered a strong second quarter, with adjusted EPS of $2.09 beating expectations and organic sales growth accelerating to 5%. The company raised its full-year 2026 adjusted EPS guidance to $8.05-$8.25, reflecting confidence in accelerating pricing and volume growth. This is the first earnings report since closing the $4.75B CoolIT Systems acquisition, and the raised outlook signals that integration is on track and underlying business momentum is building. The stock is likely to react positively to the beat and raise, especially given the recent acquisition-related uncertainty.
At the time of this filing, ECL was trading at $272.00 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $76.4B. The 52-week trading range was $243.15 to $309.27. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.